Short-Acting Antacids has 9 known drug interactions based on U.S. FDA drug labeling data. Of these, 2 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Albuterol Sulfate, Levalbuterol Tartrate, Avutometinib Potassium And Defactinib Hydrochloride. Patients taking Short-Acting Antacids should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 9
- Contraindicated
- 2
- Moderate
- 6
- Minor
- 1
Contraindicated (2)
- Short-Acting Antacids + Albuterol Sulfate— Should not be used concomitantly with Albuterol Sulfate Inhalation Aerosol due to risk of potentiating effects.
- Short-Acting Antacids + Levalbuterol Tartrate— Should not be used concomitantly with levalbuterol tartrate; may potentiate effects and cause deleterious cardiovascular…
Moderate (6)
- Short-Acting Antacids + Avutometinib Potassium And Defactinib Hydrochloride— If use cannot be avoided, administer FAKZYNJA 2 hours before or 2 hours after the antacid to minimize exposure reduction…
- Short-Acting Antacids + Cefuroxime Axetil— Reduce gastric acidity and may lower bioavailability of cefuroxime axetil. Administer at least 1 hour before or 2 hours …
- Short-Acting Antacids + Fluoxetine Hydrochloride— Caution advised with concomitant administration; consider lower initial doses, conservative titration, and clinical moni…
- Short-Acting Antacids + Olanzapine And Fuoxetine— Caution advised with concomitant CNS-active drugs; consider lower initial doses and conservative titration schedules.
- Short-Acting Antacids + Olanzapine And Samidorphan L-Malate— Concomitant use may potentiate orthostatic hypotension observed with olanzapine. LYBALVI should be used with caution.
- Short-Acting Antacids + Selpercatinib— Concomitant use decreases selpercatinib plasma concentrations, which may reduce anti-tumor activity. Avoid coadministrat…
Minor (1)
- Short-Acting Antacids + Aclidinium Bromide— Concurrent administration showed no increases in adverse drug reactions in clinical studies.